Results 51 to 60 of about 69,426 (314)

From cramming to binge‐watching: Integrating documentary‐based assessment into a pharmacology and toxicology curriculum—a qualitative study

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims In the context of pharmacology and toxicology education, there is a growing shift toward programmatic assessment models that prioritize longitudinal learning, reflection and development of higher‐order cognitive skills. As part of this transition, we are exploring alternative and more meaningful forms of assessment. This qualitative study
Narin Akrawi, Heleen van der Sijs, Floor van Rosse   +2 more
wiley   +1 more source

SARS-CoV-2 Treatment: Current Therapeutic Options and the Pursuit of Tailored Therapy

Applied Sciences, 2021
One year on from the worldwide outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), medicine has made several steps towards increasing the therapeutic options against its treatment.
Gianmarco Marcianò, Roberta Roberti, Caterina Palleria, Davida Mirra, Vincenzo Rania, Alessandro Casarella, Giovambattista De Sarro, Luca Gallelli   +7 more
doaj   +1 more source

Reported adverse drug reactions during the use of inhaled steroids in children with asthma in the Netherlands [PDF]

, 2006
Objective: Inhaled corticosteroids (ICS) are widely used in the treatment of asthma. We studied the suspected adverse drug reactions (sADRs) reported during the use of ICS in the Netherlands. Methods: In the Netherlands, health professionals and patients
de Jong-van den Berg, L.T.W., de Vries, T.W., Duiverman, E.J., Langen-Wouterse, J.J., van Puijenbroek, E.   +4 more
core   +1 more source

Evaluating and leveraging large language models in clinical pharmacology and therapeutics assessment: From exam takers to exam shapers

British Journal of Clinical Pharmacology, EarlyView.
Aims In medical education, the ability of large language models (LLMs) to match human performance raises questions about their potential as educational tools. This study evaluates LLMs' performance on Clinical Pharmacology and Therapeutics (CPT) exams, comparing their results to medical students and exploring their ability to identify poorly formulated
Alexandre O. Gérard, Diane Merino, Marc Labriffe, Fanny Rocher, Delphine Viard, Laurence Zemori, Thibaud Lavrut, Erik M. Donker, Joost D. Piët, Jean‐Paul Fournier, Milou‐Daniel Drici, Alexandre Destere   +11 more
wiley   +1 more source

The association between coronavirus disease 2019 vaccination during pregnancy and neonatal health outcomes

Pediatric Investigation
Importance Pregnant women have a higher risk of severe illness or complications due to a severe acute respiratory syndrome coronavirus 2 infection. To reduce these risks, pregnant women are advised to coronavirus disease 2019 (COVID‐19) vaccination ...
Petra J. Woestenberg, Veronique Y. F. Maas, Lieke C. M. Vissers, Nadia M. B. Oliveri, Agnes C. Kant, Maud deFeijter   +5 more
doaj   +1 more source

Signal Management: Updated Requirements of the EAEU Good Pharmacovigilance Practice

Безопасность и риск фармакотерапии, 2023
The Rules of Good Pharmacovigilance Practice of the Eurasian Economic Union (EAEU GVP Guideline) came into force in the EAEU Member States in 2017.
A. V. Matveev, A. E. Krasheninnikov, A. Yu. Zelinskaya   +2 more
doaj   +1 more source

Profiling risk factors for chronic uveitis in juvenile idiopathic arthritis: a new model for EHR-based research. [PDF]

, 2013
BackgroundJuvenile idiopathic arthritis is the most common rheumatic disease in children. Chronic uveitis is a common and serious comorbid condition of juvenile idiopathic arthritis, with insidious presentation and potential to cause blindness. Knowledge
Bauer-Mehren, Anna, Cole, Tyler S, Frankovich, Jennifer, Iyer, Srinivasan, Lependu, Paea, Shah, Nigam H   +5 more
core   +3 more sources

Age‐related differences in hydroxychloroquine‐associated adverse events: A pharmacovigilance study based on the FDA Adverse Event Reporting System

British Journal of Clinical Pharmacology, EarlyView.
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun, Jingrong Yang, Lei Wan, Xia Xu, Jing Wang   +4 more
wiley   +1 more source

Health-related quality of life in women with breast cancer: a review of measures

BMC Cancer, 2022
Background To identify and describe the breast cancer–specific health-related quality of life (HRQoL) instruments with evidence of validation in the breast cancer population for potential use in patients treated for breast cancer (excluding surgery ...
Maribel Salas, Margaret Mordin, Colleen Castro, Zahidul Islam, Nora Tu, Michelle D. Hackshaw   +5 more
doaj   +1 more source

Hospital doctors' views and concerns about pharmacovigilance [PDF]

, 2015
Purpose: The aim of the study was to evaluate the opinions and concerns of hospital doctors about adverse drug reactions (ADRs) and pharmacovigilance.
Arnau de Bolós, Josep M., Castañeda, P. F., Esterlich, E., Pedrós, Consuelo, Quijada Manuitt, M. Angeles, Quintana, B., Simón, C. P., Vallano Ferraz, Antonio   +7 more
core   +2 more sources